Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. (Record no. 22547019)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01968 a2200565 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516135908.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201305s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1474-4457 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S1473-3099(13)70005-7 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Bejon, Philip |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20130510 |
245 00 - TITLE STATEMENT | |
Title | Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Lancet. Infectious diseases |
Date of publication, distribution, etc. | Apr 2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 319-27 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adjuvants, Immunologic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Africa |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child, Preschool |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase II as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Transmission, Infectious |
General subdivision | prevention & control |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Malaria Vaccines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Malaria, Falciparum |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multivariate Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Plasmodium falciparum |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Poisson Distribution |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Primary Prevention |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proportional Hazards Models |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Severity of Illness Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccination |
General subdivision | methods |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | White, Michael T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Olotu, Ally |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bojang, Kalifa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lusingu, John P A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salim, Nahya |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Otsyula, Nekoye N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Agnandji, Selidji T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Asante, Kwaku Poku |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Owusu-Agyei, Seth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abdulla, Salim |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ghani, Azra C |
773 0# - HOST ITEM ENTRY | |
Title | The Lancet. Infectious diseases |
Related parts | vol. 13 |
-- | no. 4 |
-- | p. 319-27 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1473-3099(13)70005-7">https://doi.org/10.1016/S1473-3099(13)70005-7</a> |
Public note | Available from publisher's website |
No items available.